Swan EndoSurgical debuts to advance GI Robotics

Olympus has partnered with investment firm Revival Healthcare Capital to co-found Swan EndoSurgical, a new company focused on developing an advanced endoluminal robotic system for gastrointestinal (GI) patient care. The joint venture involves a potential investment of up to $458 million, with Revival holding a majority equity stake and Olympus maintaining significant participation and an option to acquire Swan at a predetermined value. This collaboration aims to enhance minimally invasive treatments by improving precision, efficiency, and ergonomics in GI procedures, building upon traditional endoscopy techniques used for early diagnosis and treatment of GI conditions such as cancer. The development of Swan EndoSurgical’s robotic system seeks to overcome the limitations of manual endoscopes by enabling flexible maneuvering and deployment of robotic arms within the GI tract, potentially allowing safer, more effective surgeries that avoid invasive methods. The company has already established an experienced leadership team and will be headquartered in the U.S. Olympus views this partnership as a strategic milestone to reshape the GI market by expanding procedural